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Galactokinase (GALK) deficiency is an autosomal recessive disorder characterized by hypergalactosemia and cataract
formation. Through mass screening of newborn infants, we identified a novel and prevalent GALK variant (des-
ignated here as the “Osaka” variant) associated with an A198Vmutation in three infants withmildGALKdeficiency.
GALK activity and the amount of immunoreactive protein in the mutant were both 20% of normal construct in
expression analysis. The Km values for galactose and ATP-Mg
2+ in erythrocytes with homozygous A198V were
similar to those of the healthy adult control subjects. A population study for A198V revealed prevalences of 4.1%
in Japanese and 2.8% in Koreans, lower incidence in Taiwanese and Chinese, no incidence in blacks and whites
from the United States, and a significantly high frequency (7.8%; ) in Japanese individuals with bilateralP ! .023
cataract. This variant probably originated in Japanese and Korean ancestors and is one of the genetic factors that
causes cataract in elderly individuals.
Galactokinase (GALK) deficiency (MIM 230200) is an
autosomal recessive disorder characterized by hyperga-
lactosemia and cataract formation if the child is not kept
on a lactose-free diet. GALK (EC 2.7.1.6) catalyzes the
first step of galactose metabolic pathway and is involved
in the conversion of galactose to galactose-1-phosphate.
The incidence of GALK deficiency is about 1/1,000,000
in whites (Segal and Berry 1995). In Japan, the incidence
of GALK deficiency is also rare (1/1,000,000), on the
basis of a mass-screening program for newborn infants
with galactosemia (Aoki and Wada 1988). The initial
studies on GALK deficiency at a molecular level resulted
in the construction of a full-length human GALK cDNA,
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which is 1.35 kb long and encodes a peptide of 392
amino acids (Stambolian et al. 1995). Subsequent studies
identified the GALK genome on chromosome 17q24,
which consists of eight exons spanning 7.3 kb (Stam-
bolian et al. 1995; Bergsma et al. 1996; Asada et al.
1999). Mutational analysis of patients with complete or
near-complete GALK deficiency identified 14 mutations
in Europe and the United States (Stambolian et al. 1995;
Kolosha et al. 2000), 5 mutations in Japanese (Asada et
al. 1999), and 1 prevalent mutation in the Romani pop-
ulation of Bulgaria (Kalaydjieva et al. 1999).
Hypergalactosemia results in accumulation of galac-
titol in the lens, which is synthesized by the reduction
of galactose by aldose reductase. The osmotic phenom-
enon of galactitol causes swelling within lens fiber cells
and eventually leads to cataract formation. Galactose
metabolism is suspected to be related to cataractogenesis
in the presence of complete (as well as partial) enzyme
deficiency in the galactose metabolic pathway, high adult
jejunal lactase activity, and/or large consumption of lac-
tose (Couet et al. 1991). Age-related cataract is a mul-
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Figure 1 Pedigrees of families 1–3. Genotype and GALK activity (in nmol/min/g hemoglobin) measured in erythrocytes of male (squares)
and female (circles) members of the families. Data in parentheses represent the percentage of GALK activity relative to that in healthy adult
control subjects (25.2–40.0 nmol/min/g hemoglobin). The age at which GALK activity was measured is indicated for probands.
Figure 2 Oral galactose–tolerance test in three patients and six
healthy control subjects. The oral galactose–tolerance test was per-
formed using a dose of 1 g of galactose/kg of body weight (maximum
50 g). Patient 1, age 1 year; patient 2, age 1 year; patient 3, age 9
mo. Shaded area, mean  SD data of the healthy control subjects,
aged 30–43 years, with normal GALK, GALT, and UDP-galactose 4′-
epimerase in erythrocytes. An asterisk (*) denotes a P value !.05,
relative to the control subjects.
tifactorial disease involving host, genetic, and environ-
mental factors. Research in age-related cataract has
focused mainly on environmental factors, which seem
to be important risk factors. However, Hammond et al.
(2000) demonstrated, on the basis of research involving
female twins, that genetic factors are most important
among several factors in age-related cataract.
In the present study, we report a new variant of GALK,
“Osaka,” which was detected during mass screening of
newborn infants in Japan. We characterized the Osaka
variant, genetically and biochemically, and demon-
strated its prevalence in Japanese and Koreans. We sus-
pect that the Osaka variant is one of the genetic factors
in cataract formation.
Three nonconsanguineous Japanese patients were re-
ferred to our hospitals for further investigation of high
galactose levels (0.19–0.52 mmol/L) detected during
mass screening of newborn infants. All three patients
had normal fluorescence in the Beutler spot test for ga-
lactose-1-phosphate uridyltransferase (GALT) activity
and showed undetectable galactose-1-phosphate and
UDP-galactose levels in thin-layer chromatography for
galactose metabolites. GALK activity in all three patients
at 1–3 months of age ranged from 19 to 34% of adult
control subjects, and diminished, in the same patients,
to 9%–14% at age 22–34 mo (fig. 1). These results
demonstrate that the mutant GALK was under the same
age-dependent regulation as the control subjects; the ac-
tivity in normal infants is two- to three-fold higher than
in normal children and adults (Ng et al. 1965). None
of the patients had cataract or other clinical manifes-
tations during the neonatal period. Follow-up studies
showed a gradual return of blood galactose concentra-
tion to the normal range, commencing at age 4 mo,
without strict lactose-free diet. In vivo metabolic rate
of galactose was determined in our study by the oral
galactose–tolerance test (fig. 2). The mean maximum
concentration of blood galactose in three patients was
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Figure 3 Identification of missense mutation in patients with the
Osaka variant. Each exon and its flanking intronic region was am-
plified with a pair of human GALK-specific oligonucleotide primers
(one primer was biotinylated) using PCR. The amplified products were
purified to single-strand DNA, using magnetic beads coated with strep-
tavidin M280 (Dynal), and were sequenced with dye terminator meth-
ods using an ABI autosequencer (310 Genetic Analyzer). Primers used
for the PCR amplification in exon 4 of the human GALK gene are as
follows: biotin-sense primer of 5′-GAATCTCCCTGGAGTGTCATT-
3′ and antisense primer of 5′-CAGGCAGTGGGCACACTCCA-3′.
Sequencing primer is sense primer of 5′-TCATTGAAGCCACTGCT-
GCT-3′. The C and T bands appear at the same position in the patients’
sequences, resulting in a CrT transition and replacement of alanine
by valine at codon 198.
Table 1
Distribution of A198V Variant among Various Races









Japanese 582 24 4.1
Japanese with cataract 296 23 7.8
Koreans 288 8 2.8
Taiwanese 264 1 .38
Chinese:
Peking 140 1 .71
Shanghai 138 0 0
United States:
Whites 188 0 0
Blacks 10 0 0
mmol/l at 60 min (mean  SD in healthy3.42 0.07
adult control subjects mmol/l). Further-2.45 0.86
more, blood galactose levels at 90 and 120 min
( and mmol/l, respectively)2.2 0.36 0.69 0.082
were significantly higher than those of the control sub-
jects ( and mmol/l, respec-0.90 0.26 0.21 0.078
tively; each, Student’s t-test). Galactose meta-P ! .001
bolic rate in these patients was lower than in the control
patients.
We suspected a novel allelic variant in the human
GALK gene in our patients, on the basis of the following
features: (1) slightly elevated blood galactose levels iden-
tified through mass screening in newborn infants, (2)
GALK activity only 10% of that in control subjects, and
(3) low metabolic rate of galactose by galactose-toler-
ance test. The above results cannot be explained by only
two concepts of normal and null or near-null enzyme
deficient-type of GALK activity, but can be clearly, the-
oretically explained by the existence of a novel variant.
Therefore, we propose the name “Osaka variant.”
To characterize the GALK gene of the Osaka variant
and to confirm Mendelian segregation, we performed
sequence analysis in three families. Among the three pa-
tients, we found a common missense mutation of CrT
transition at nucleotide position 593 of the GALK ge-
nomic gene (GenBank accession numbers L76927 and
AF084935) in exon 4, resulting in the replacement of
alanine (GCG) by valine (GTG) at codon 198 (A198V)
(fig. 3). GALK activities and transmission of the A198V
mutation in three GALK deficient families are shown in
figure 1. All three patients showed a compound hetero-
zygote of the A198V mutation and severe phenotype
mutation of GALK activities and genotypes. In patient
1, we identified another mutation: two nucleotide de-
letions of 509-510 del GT (Asada et al. 1999). Patient
2 had another mutation; a missense mutation of M1I
with GALK activity of 3% of normal on expression anal-
ysis (Kolosha et al. 2000). In family 1, the father (GALK
activity was 23% of that in adult healthy control sub-
jects) was homozygous for the A198V mutation. The
above results indicate that the A198V mutation is trans-
mitted from parents (fathers) to patients, and is asso-
ciated with a reduction of GALK activity to 20% of that
in the control subjects.
To determine whether the A198V mutation was as-
sociated with a low enzyme activity and to assess the
potential GALK activity of the A198V mutation, we
reconstructed A198V mutant in the expression vector
pCDNA3 by site-directed mutagenesis. Mutant and
normal GALK cDNAs were introduced into COS cells
by electroporation with a Gene Pulser (Bio-Rad) as
described previously (Ashino et al. 1995). The normal
GALK cDNA inserted into COS cells in a transient ex-
pression assay led to 8–10-fold stimulation of GALK
activity (10.7 U/mg protein) compared to the endoge-
nous background (1.35 U/mg protein). GALK activity
and immunoreactive amount of the A198V construct
was established by correcting the transfection efficiency
into COS cells (fig. 4). GALK activity of A198V con-
struct was reduced to 18.5% of normal construct, which
corresponded to 20% GALK activity in erythrocytes of
the father with A198V/A198V in family 1. Immuno-
reactive protein of the A198V construct was also re-
duced to 20% of normal construct by the densitometric
analysis. The A198V substitution was a causal gene for
partial GALK deficiency in the probands, and the low
GALK activity correlated with the reduced amount of
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Figure 4 Analysis of GALK mRNA, immunoreactive protein, and GALK activity in COS cells transfected with normal or A198V human
GALK cDNAs constructs.A,GALKmRNA levels in cell extracts were determined by dot-blot hybridization for serially diluted samples containing
1, 2, 4, or 8 mg of total RNA with a GALK cDNA probe labeled with [a-32P] dCTP. The levels of GALK activity and immunoreactive protein
were corrected with transfection efficiency by these levels of GALK mRNA. B, Immunoreactive GALK was identified by Western blotting, using
a rabbit anti-human GALK antibody, goat anti-rabbit IgG-peroxidase, and ECL system (Amersham Pharmacia Biotech). The density of each
band was quantified by scanning with a Bio-Rad Imaging Densitometer (GS-700).C,GALK activity was determined twice to ensure reproducibility
using 14C-galactose and a diethylaminoethyl cellulose column-DE52, as described elsewhere (Shin Buehring et al. 1977). GALK activities in
normal, A198V, or mock constructs were expressed as nmol phosphorylated galactose/min/mg protein. The level of GALK activity in the A198V
mutant construct was expressed as a percentage between those of normal constructs (100%) and endogenous background (0%).
GALK protein. These results define A198V as novel and
as the first mutation detected from a variant with a mild
clinical phenotype. So far, two variants have been iden-
tified: the Philadelphia and Urbino variants (Tedesco et
al. 1972, 1977;Magnani et al. 1982). The Osaka variant
appears to differ from the Philadelphia and Urbino var-
iants with respect to the following features: (1) Phila-
delphia and Urbino variants have been detected in blacks
and in Italians, respectively, whereas the Osaka variant
was detected in Japanese and Koreans, and (2) GALK
activity of Philadelphia and Urbino variants is 70% and
50%, respectively, of that in the control subjects.
To determine whether the cause of low GALK activity
in the A198V mutation is a reduced catalytic rate or a
low number of GALK molecules, we determined the ki-
netic parameters of GALK activity ( and ) inK Vm max
erythrocytes with A198V/A198V (the father of patient
1) or normal/normal for galactose and ATP-Mg2. Km
and values were calculated using linear regressionVmax
analysis and extrapolated intercepts from Michaelis-
Menten and Lineweaver-Burk plots. The values forKm
galactose in normal and mutant were and41.06# 10
moles, respectively. The values for ga-41.17# 10 Vmax
lactose in normal and mutant were 27.0 and 5.89 nmol/
min/g hemoglobin, respectively. The values for ATP-Km
Mg2 in normal and mutant were moles43.09# 10
and moles, respectively. The values for43.30# 10 Vmax
ATP-Mg2 in normal and mutant were 26.9 and 9.17
nmol/min/g hemoglobin, respectively. The values forKm
galactose and ATP-Mg2 in erythrocytes of patients ho-
mozygous for A198V mutation were similar those in
normal. The in erythrocytes of A198V/A198V ge-Vmax
notype was one-third to one-fifth of that in normal/nor-
mal. Furthermore, the amount of immunoreactive pro-
tein of A198V was 18.5% of normal. The low GALK
activity in A198V mutation is caused by instability of
mutant GALK proteins. Functional abnormality of the
A198V mutation is also suspected, because of the po-
sition of this mutation in the alignment of the predicted
galactokinase protein. The A198V mutation in exon 4
was not in the conserved sequence of the homologous
enzymes from Streptomyces lividans (Adams et al. 1988)
and was not in the signature sequence and the ATP-
binding domain (Debouck et al. 1985; Tsay and Rob-
inson 1991). It is speculated that the A198V mutation
does not have strong effects on the structure of GALK
protein.
The population frequency of the A198V was analyzed
in samples of anonymized control children without a
diagnosis and family history of GALK deficiency, se-
lected from hospitals. Genomic DNA was purified from
dried blood spots obtained from subjects using the
ReadyAmp Genomic DNA Purification System. We ex-
amined the frequency of A198V mutation in Japanese,
Koreans, Taiwanese, Chinese, and whites and blacks
from the United States, using the mutant allele–specific
amplification. The A198V mutant gene was easily iden-
tified, as shown in figure 5. The frequency of the A198V
mutation varied widely according to racial background
(table 1). The highest frequency of the A198V mutant
gene was among Japanese, amounting to 4.1% in 291
Japanese (24/582 alleles), followed by Koreans (2.8%).
Only one of each allele was detected in Taiwanese and
Chinese, and no mutant alleles were found in whites and
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Figure 5 Allele-specific amplification for A198V mutation. Primers A198-AS for normal and 198V-AS for mutant type had the mismatch
at the 3′ end and a deliberate G/A mismatch at three bases from the 3′ ends due to improvement of specificity between normal and A198V
mutation. The following primer sets were used for PCR: antisense primer of A198-AS: 5′-CCTGCAGTCAATGAGCAACG-3′ for normal, or
of 198V-AS: 5′-CCTGCAGTCAATGAGCAACA-3′ for A198V mutation, and sense primer of 198-S: 5′-GAATCTCCCTGGAGTGTCATT-3′ for
normal and A198V mutation. Lane 1, PCR product (213 bp) shows only A198V amplification, indicating that the subject from whom this
sample was taken is homozygous for A198V mutation. Lanes 2 and 3, PCR products show both normal and A198V mutant amplifications.
The subjects of lanes 2 and 3 are heterozygous carriers of A198V mutation. Lanes 4 to 8, PCR products show only normal amplification. These
subjects had the normal genotype. MW p molecular weight marker (100-bp ladder).
blacks from the United States. Unfortunately, the sample
size of blacks was not sufficiently large to allow a firm
conclusion regarding the exact frequency of the A198V
mutant gene. Because our data showed that the carrier
frequency of the Osaka variant is 1/12 (7.9%), the es-
timated frequencies of homozygote with the Osaka var-
iant (20% GALK activity) and compound heterozygote
with the Osaka variant and severe phenotype (10%
GALK activity) is 1/600 and 1/24,000, respectively. We
detected 3 patients in 20,000 per year in the annual mass
screening, over a period of 4 years. The genetic frequency
of the Osaka variant is similar to that of the Duarte
variant of GALT deficiency (MIM 230400) in the United
States (5.9%) (Elsas et al. 1994; Lin et al. 1994) and
Japan (2%) (Ichiba 1989), which is a common variant
among various races worldwide and is suspected to have
arisen before racial divergence (Lin and Reichardt 1995;
Hirokawa et al. 1999). On the other hand, the Osaka
variant is common among Koreans and Japanese, with
a high frequency of 2.8%–4.1%. However, this variant
is rare among other Asians (i.e., Taiwanese and Chinese)
and is absent among Caucasians. We suspect that the
Osaka variant (A198V mutation) originated in the com-
mon ancestors of Koreans and Japanese and that the
origin of this variant is relatively new, compared with
the Duarte variant.
In the present study, three patients had 10% of GALK
activity and delayed galactose metabolism, on the basis
of the results of the galactose-tolerance test. The long-
term effects of intermittent episodes of hypergalacto-
semia caused by partial GALK deficiency on the lens
structure and function are not clear. Accordingly, we
examined the relationship between A198Vmutation and
cataract formation to estimate the long-term effects of
reduced GALK activity by the Osaka variant and the
requirement of strict lactose-free diet in patients with the
Osaka variant. We examined the relationship between
A198V and cataract by screening for the A198V allele
in patients with bilateral idiopathic cataract sufficiently
advanced to require cataract surgery in at least one eye.
All patients were 155 years of age. Genomic DNA was
isolated from lymphocytes, and the detection of A198V
mutation was performed as described above. The fre-
quency of A198V mutation in such patients was 7.8%,
which was significantly higher than in the general Jap-
anese population (4.1%; ; test). Among 1482Pp .023 x
patients with cataract, 2 homozygous and 19 hetero-
zygous patients with the Osaka variant (A198V) were
identified. Our results showed a significant correlation
between the A198V mutation and cataract. Our three
probands and one brother in family 1 still remain on a
very mild restriction of lactose intake.
Age-related cataract is a major public health problem
because of its high prevalence, which amounts to
15%–20% among sexagenarian subjects (Kahn et al.
1977; Sasaki et al. 1987; Sommer et al. 1991). The risk
factors of age-related cataract are multifactorial and in-
clude host factors (age, sex, race, and genetic factors)
and environmental factors (smoking, food, daylight,
medicines, and education). Galactose has also been sus-
pected to influence cataractogenesis for the following
reasons: (1) aging is directly associated with lower met-
abolic capacity and lower erythrocyte GALK and/or
GALT activities (Birlouez-Aragon et al. 1993); (2) a
chronic impairment of galactose metabolism (partial de-
ficiency of GALT and GALK, including in heterozygotes)
is involved in the pathogenesis of presenile and senile
cataract (Monteleone et al 1971; Skalka and Prchal
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1980; Stambolian et al. 1986; Simonelli et al. 1992); and
(3) the consumption of milk and lactase activity, reflect-
ing the amount of galactose absorption, is associated
with a high incidence of cataract (Simoons 1982; Rinaldi
et al. 1984; Bhatnagar et al. 1989; Simonelli et al. 1989).
However, the incidence of typical GALK deficiency is
generally low (1/1,000,000) worldwide, and the fre-
quency of carriers is also too low (1/500) to explain the
high incidence of the age-related cataract formation. On
the other hand, our data showed that the Osaka variant
is prevalent, with a carrier frequency of 1/12 (7.9%) in
the general population. Furthermore, the Osaka variant
tended to concentrate in patients with cataract (the car-
rier frequency is 1/7 [14.4%]). Another characteristic of
the Osaka variant in relation to cataract formation is
an 80% reduction of GALK activity. The GALK activity
(60% of that in healthy subjects) in carriers of the Osaka
variant is similar to that (50%) in carrier for complete
GALK deficiency. In this regard, Hammond et al. (2000)
reported that genetic factors are most important among
the various factors causing cataract in the elderly. The
Osaka variant is the first genetic variant that could di-
rectly explain the role of genetic factors in the devel-
opment of cataract in elderly Japanese and Koreans.
Further research may allow the identification of similar
variants in other races.
The protocols of the studies described in this report
were approved by the institutional review boards of
Osaka City Environment and Public Heath Association
and Osaka City University Graduate School of Medi-
cine. Informed consent for genetic analysis was obtained
from all patients or their parents.
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
GenBank, http://www.ncbi.nlm.nih.gov/Web/Genbank/index
.html (for the sequence of the human GALK gene [accession
numbers L76927 and AF084935])
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim (for GALK deficiency [MIM
230200] and galactosemia caused by GALTdeficiency [MIM
230400])
References
Adams CW, Fornwald JA, Schmidt FJ, Rosenberg M, Brawner
ME (1988) Gene organization and structure of the Strep-
tomyces lividans gal operon. J Bacteriol 170:203–212
Aoki K, Wada Y (1988) Outcome of the patients detected by
newborn screening in Japan. Acta Paediatr Jpn 30:429–434
Asada M, Okano Y, Imamura T, Suyama I, Hase Y, Isshiki G
(1999) Molecular characterization of galactokinase defi-
ciency in Japanese. J Hum Genet 44:377–382
Ashino J, Okano Y, Suyama I, Yamazaki T, Yoshino M, Fu-
ruyama J, Lin HC, Reichardt JKV, Isshiki G (1995) Molec-
ular characterization of galactosemia (type 1) mutations in
Japanese. Hum Mutat 6:36–43
Bergsma DJ, Ai Y, Skach WR, Nesburn K, Anoia E, Van Horn
S, Stambolian D (1996) Fine structure of the human gal-
actokinase GALK1 gene. Genome Res 6:980–985
Bhatnagar R, Sharma Y, Mohan M, Vajpayee RB, Azad RV,
Mukesh K (1989) Does milk have a cataractogenic effect: a
weighing of clinical evidence. Dev Ophthalmol 17:93–96
Birlouez-Aragon I, Ravelontseheno L, Villate-Cathelineau B,
Cathelineau G, Abitbol G (1993) Disturbed galactose me-
tabolism in elderly and diabetic humans is associated with
cataract formation. J Nutr 123:1370–1376
Couet C, Jan P, Debry G (1991) Lactose and cataract in hu-
mans: a review. J Am Coll Nutr 10:79–86
Debouck C, Riccio A, Schumperli D, McKenney K, Jeffers J,
Hughes C, Rosenberg M, Heusterspreute M, Brunel F, Dav-
ison J (1985) Structure of the galactokinase gene of Es-
cherichia coli, the last (?) gene of the gal operon. Nucleic
Acids Res 13:1841–1853
Elsas LJ, Dembure PP, Langley S, Paulk EM, Hjelm LN, Fri-
dovich-Keil JL (1994) A common mutation associated with
the Duarte galactosemia allele. Am J Hum Genet 54:
1030–1036
Hammond CJ, Snieder H, Spector TD, Gilbert CE (2000) Ge-
netic and environmental factors in age-related nuclear cat-
aracts in monozygotic and dizygotic twins. N Engl J Med
342:1786–1790
Hirokawa H, Okano Y, Asada M, Fujimoto A, Suyama I,
Isshiki G (1999) Molecular basis for phenotypic heteroge-
neity in galactosaemia: prediction of clinical phenotype from
genotype in Japanese patients. Eur J Hum Genet 7:757–764
Ichiba Y (1989) The variant of galactosemia. Jpn J Pediatr 42:
579–582
Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T,
Nickerson RS, Dawber TR (1977) The Framingham Eye
Study. II. Association of ophthalmic pathology with single
variables previously measured in the Framingham Heart
Study. Am J Epidemiol 106:33–41
Kalaydjieva L, Perez-Lezaun A, Angelicheva D, Onengut S,
Dye D, Bosshard NU, Jordanova A, Savov A, Yanakiev P,
Kremensky I, Radeva B, Hallmayer J, Markov A, Nedkova
V, Tournev I, Aneva L, Gitzelmann R (1999) A founder
mutation in the GK1 gene is responsible for galactokinase
deficiency in Roma (Gypsies). Am J Hum Genet 65:
1299–1307
Kolosha V, Anoia E, de Cespedes C, Gitzelmann R, Shih L,
Casco T, Saborio M, Trejos R, Buist N, Tedesco T, Skach
W, Mitelmann O, Ledee D, Huang K, Stambolian D (2000)
Novel mutations in 13 probands with galactokinase defi-
ciency. Hum Mutat 15:447–453
Lin H-C, Kirby LT, Ng WG, Reichardt JKV (1994) On the
molecular nature of the Duarte variant of galactose-1-phos-
phate uridyl transferase (GALT). Hum Genet 93:167–169
Lin H-C, Reichardt JKV (1995) Linkage disequilibrium be-
tween a Sac I restriction fragment length polymorphism and
two galactosemia mutations. Hum Genet 95:353–355
Magnani M, Cucchiarini L, Dacha M, Fornaini G (1982) A
new variant of galactokinase. Hum Hered 32:329–334
1042 Am. J. Hum. Genet. 68:1036–1042, 2001
Monteleone JA, Beutler E, Monteleone PL, Utz CL, Casey EC
(1971) Cataracts, galactosuria and hypergalactosemia due
to galactokinase deficiency in a child: studies of a kindred.
Am J Med 50:403–407
Ng WG, Donnell GN, Bergren WR (1965) Galactokinase ac-
tivity in human erythrocytes of individuals at different ages.
J Lab Clin Med 66:115–121
Rinaldi E, Albini L, Costagliola C, De Rosa G, Auricchio G,
De Vizia B, Auricchio S (1984) High frequency of lactose
absorbers among adults with idiopathic senile and presenile
cataract in a population with a high prevalence of primary
adult lactose malabsorption. Lancet 8373:355–357
Sasaki K, Karino K, Kojima M, Sakamoto Y, Takizawa A,
Zeinuddin D, Katou N (1987) Cataract survey in the local
area using photographic documentation. Dev Ophthalmol
15:28–36
Segal S, Berry G (1995) Disorders of galactose metabolism.
In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic
and molecular bases of inherited disease. McGraw-Hill,
New York, pp 967–1000
Shin Buehring YS, Osang M, Ziegler R, Schaub J (1977) A
simple assay for galactokinase using DEAE-cellulose column
chromatography. Clin Chim Acta 74:1–5
Simonelli F, Giovane A, Frunzio S, Balestrieri P, Amicone A,
Rinaldi M, Cotticelli L, Rinaldi E (1992) Galactokinase ac-
tivity in patients with idiopathic presenile and senile cata-
ract. Metab Pediatr Syst Ophthalmol 15:53–56
Simonelli F, Nesti A, Picardi A, Napoli R, De Rosa G, Lauro
G, Di Meo A, Rinaldi E, Auricchio G (1989) Cataract for-
mation in patients with lactose and galactose disorders. Dev
Ophthalmol 17:82–86
Simoons FJ (1982) A geographic approach to senile cataracts:
possible links with milk consumption, lactase activity, and
galactose metabolism. Dig Dis Sci 27:257–264
Skalka HW, Prchal JT (1980) Presenile cataract formation and
decreased activity of galactosemic enzymes. Arch Ophthal-
mol 98:269–273
Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt
JC, Martone JF, Royall RM,Witt KA, Ezrine S (1991) Racial
differences in the cause-specific prevalence of blindness in
East Baltimore. N Engl J Med 325:1412–1417
Stambolian D, Ai Y, Sidjanin D, Nesburn K, Sathe G, Rosen-
berg M, Bergsma DJ (1995) Cloning of the galactokinase
cDNA and identification of mutations in two families with
cataracts. Nat Genet 10:307–312
Stambolian D, ScarpinoMyers V, Eagle RC Jr, Hodes B, Harris
H (1986) Cataracts in patients heterozygous for galactoki-
nase deficiency. Invest Ophthalmol Vis Sci 27:429–433
Tedesco TA, Bonow R, Miller KL, Mellman WJ (1972) Gal-
actokinase: evidence for a new racial polymorphism. Science
178:176–178
Tedesco TA, Miller KL, Rawnsley BE, Adams MC, Markus
HB, Orkwiszewski KG, Mellman WJ (1977) The Philadel-
phia variant of galactokinase. Am J HumGenet 29:240–247
Tsay YH, Robinson GW (1991) Cloning and characterization
of ERG8, an essential gene of Saccharomyces cerevisiae that
encodes phosphomevalonate kinase. Mol Cell Biol 11:
620–631
